You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PEGPH20

Showing 1 - 21 of 21
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Cancer, Advanced Pancreatic Ductal Adenocarcinoma Trial in United States (Gemcitabine, Nab-paclitaxel, PEGPH20)

Active, not recruiting
  • Pancreatic Cancer
  • Advanced Pancreatic Ductal Adenocarcinoma
  • Hartford, Connecticut
  • +9 more
Jul 15, 2022

Pancreatic Ductal Adenocarcinoma Trial in New York (Atezolizumab, PEGPH20)

Terminated
Has Results
  • Pancreatic Ductal Adenocarcinoma
  • New York, New York
    Columbia University
Dec 1, 2020

Metastatic Breast Cancer Trial in United States (Eribulin mesylate, Biologic: PEGylated recombinant human hyaluronidase

Terminated
Has Results
  • Metastatic Breast Cancer
  • Eribulin mesylate
  • +2 more
  • Whittier, California
  • +6 more
Jun 25, 2020

Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in Houston (Pegylated Recombinant Human

Withdrawn
  • Metastatic Pancreatic Adenocarcinoma
  • Stage IV Pancreatic Cancer AJCC v8
  • Pegylated Recombinant Human Hyaluronidase PH20
  • Pembrolizumab
  • Houston, Texas
    M D Anderson Cancer Center
Mar 11, 2020

Pancreatic Ductal Adenocarcinoma Trial in Philadelphia (Pegvorhyaluronidase alfa, Abraxane, Gemcitabine)

Withdrawn
  • Pancreatic Ductal Adenocarcinoma
  • Pegvorhyaluronidase alfa
  • +2 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center at University of Pennsylvania
Jan 30, 2020

Adenocarcinoma Trial in San Francisco (PEGPH20, Gemcitabine, Nab-paclitaxel)

Terminated
Has Results
  • Adenocarcinoma
  • PEGPH20
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Dec 16, 2019

Pancreas Adenocarcinoma Trial (Gemcitabine)

Withdrawn
  • Pancreas Adenocarcinoma
  • (no location specified)
Jan 6, 2020

Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal Carcinoma Trial in Worldwide (5-Fluorouracil

Recruiting
  • Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal Carcinoma
  • 5-Fluorouracil (5-FU)
  • +11 more
  • Scottsdale, Arizona
  • +41 more
Jan 19, 2023

Cholangiocarcinoma Non-resectable, Cholangiocarcinoma, Intrahepatic, Cholangiocarcinoma, Extrahepatic Trial in Korea, Republic

Terminated
Has Results
  • Cholangiocarcinoma Non-resectable
  • +3 more
  • PEGPH20
  • +3 more
  • Phoenix, Arizona
  • +35 more
Jan 24, 2020

Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer Trial in Fuenlabrada, Madrid (PEGylated Recombinant Human Hyaluronidase

Terminated
  • Pancreatic Ductal Adenocarcinoma
  • Pancreatic Cancer
  • PEGylated Recombinant Human Hyaluronidase (PEGPH20)
  • Avelumab
  • Fuenlabrada, Madrid, Spain
  • +2 more
Aug 20, 2019

Metastatic Pancreatic Cancer Trial in United States (PEGPH20, Nab-paclitaxel, Gemcitabine)

Completed
Has Results
  • Metastatic Pancreatic Cancer
  • PEGPH20
  • +4 more
  • Birmingham, Alabama
  • +50 more
Jul 6, 2020

Metastatic Pancreatic Adenocarcinoma Trial in United States (PEGPH20, Oxaliplatin, Leucovorin)

Active, not recruiting
Has Results
  • Metastatic Pancreatic Adenocarcinoma
  • PEGPH20
  • +4 more
  • Anchorage, Alaska
  • +153 more
Nov 29, 2021

NSCLC, Gastric Cancer Trial in United States (PEGPH20, Pembrolizumab)

Completed
Has Results
  • NSCLC
  • Gastric Cancer
  • Birmingham, Alabama
  • +27 more
Jan 24, 2020

Pancreatic Adenocarcinoma Non-resectable Trial in La Jolla (PEGylated Recombinant Human Hyaluronidase (PEGPH20), Gemcitabine,

Terminated
  • Pancreatic Adenocarcinoma Non-resectable
  • PEGylated Recombinant Human Hyaluronidase (PEGPH20)
  • +2 more
  • La Jolla, California
    Scripps Cancer Center
Apr 9, 2019

NSCLC Trial in United States (PEGylated recombinant human hyaluronidase PH20, Docetaxel)

Terminated
Has Results
  • Non-small Cell Lung Cancer
  • PEGylated recombinant human hyaluronidase PH20
  • Docetaxel
  • Encinitas, California
  • +7 more
Feb 5, 2019

Stage IV Pancreatic Cancer Trial in Russian Federation, United States (Gemcitabine, PEGPH20, Placebo)

Completed
Has Results
  • Stage IV Pancreatic Cancer
  • Fayetteville, Arkansas
  • +11 more
Oct 29, 2018

Pancreatic Ductal Carcinoma Trial in Worldwide (Biological: PEGylated Recombinant Human Hyaluronidase (PEGPH20), Placebo,

Terminated
Has Results
  • Pancreatic Ductal Carcinoma
  • Biological: PEGylated Recombinant Human Hyaluronidase (PEGPH20)
  • +3 more
  • Mobile, Alabama
  • +216 more
Jun 30, 2020

Pancreatic Cancer Trial in Montpellier (Biological collection)

Recruiting
  • Pancreatic Cancer
  • Biological collection
  • Montpellier, Occ, France
    Institut Régional du Cancer de Montpellier
Jun 16, 2021

Pancreatic Cancer Trial in New York (drug, device, other)

Completed
Has Results
  • Pancreatic Cancer
  • PEGPH20
  • +3 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Sep 25, 2017

Solid Tumor Trial in United States (PEGPH20)

Completed
  • Solid Tumor
  • PEGPH20
  • Scottsdale, Arizona
  • +4 more
Jan 27, 2014

Solid Tumor Trial in Scottsdale, Santa Monica, Nashville (PEGPH20)

Completed
  • Solid Tumor
  • PEGPH20
  • Scottsdale, Arizona
  • +2 more
Mar 24, 2013